-
Mashup Score: 22Breast Cancer: New Horizons, Current Controversies - 20 day(s) ago
Breast Cancer: New Horizons, Current Controversies is a comprehensive educational curriculum that encompasses the full range of breast cancer care. Topics include mechanisms of disease, improvements in diagnostic methods, treatment innovations, and management of breast cancer survivors. The primary goal of the course is to improve the knowledge, competence, and clinical skills of healthcare professionals who specialize in oncology. As such, the curriculum is well suited for medical, surgical, and radiation oncologists; breast and general surgeons; internists; physician assistants; nurse practitioners; oncology nurses; and other clinicians involved in the care of breast cancer patients. The two-day course is taught by clinical experts in medical oncology, surgical oncology, radiation oncology, and pathology. Each year, the course faculty identify emerging practice gaps in breast oncology and address those gaps by translating the latest scientific knowledge into practical clinical app
Source: cmecatalog.hms.harvard.eduCategories: General Medicine NewsTweet
-
Mashup Score: 18
This intensive course, developed by the International Society for Stem Cell Research (ISSCR), offers a comprehensive exploration of key topics in stem cell medicine. Designed for clinicians, medical students, and health care professionals, the curriculum is structured into seven modules providing an overview of the field, from basic stem cell biology and clinical trials to ethical considerations surrounding unproven stem cell interventions and patient communication.Through expert-led lectures, this course equips health care providers with the knowledge needed to guide patients toward informed, evidence-based decisions while protecting them from unsafe and unproven treatments. It promotes responsible practices and aims to ensure that clinicians are well-prepared to navigate the challenges and opportunities presented by stem cell medicine, ultimately prioritizing patient health and safety.
Source: cmecatalog.hms.harvard.eduCategories: General Medicine News, NeurologyTweet-
If you are a #clinician interested in the future of stem cell medicine, please get your certificate of completion of our FREE online course @HMS and @ISSCR @JAMA_current #STEMCELLMEDICINE @ISSCR @harvardmed https://t.co/hYAJNyjD8S https://t.co/p76IgsRoGr
-
-
Mashup Score: 19
This intensive course, developed by the International Society for Stem Cell Research (ISSCR), offers a comprehensive exploration of key topics in stem cell medicine. Designed for clinicians, medical students, and health care professionals, the curriculum is structured into seven modules providing an overview of the field, from basic stem cell biology and clinical trials to ethical considerations surrounding unproven stem cell interventions and patient communication.Through expert-led lectures, this course equips health care providers with the knowledge needed to guide patients toward informed, evidence-based decisions while protecting them from unsafe and unproven treatments. It promotes responsible practices and aims to ensure that clinicians are well-prepared to navigate the challenges and opportunities presented by stem cell medicine, ultimately prioritizing patient health and safety.
Source: cmecatalog.hms.harvard.eduCategories: General Medicine News, NeurologyTweet-
If you are a #clinician interested in the future of stem cell medicine, please get your certificate of completion of our FREE online course @HMS and @ISSCR @JAMA_current #STEMCELLMEDICINE @ISSCR @harvardmed https://t.co/hYAJNyjD8S https://t.co/p76IgsRoGr
-
-
Mashup Score: 22Breast Cancer: New Horizons, Current Controversies - 1 month(s) ago
Breast Cancer: New Horizons, Current Controversies is a comprehensive educational curriculum that encompasses the full range of breast cancer care. Topics include mechanisms of disease, improvements in diagnostic methods, treatment innovations, and management of breast cancer survivors. The primary goal of the course is to improve the knowledge, competence, and clinical skills of healthcare professionals who specialize in oncology. As such, the curriculum is well suited for medical, surgical, and radiation oncologists; breast and general surgeons; internists; physician assistants; nurse practitioners; oncology nurses; and other clinicians involved in the care of breast cancer patients. The two-day course is taught by clinical experts in medical oncology, surgical oncology, radiation oncology, and pathology. Each year, the course faculty identify emerging practice gaps in breast oncology and address those gaps by translating the latest scientific knowledge into practical clinical app
Source: cmecatalog.hms.harvard.eduCategories: General Medicine NewsTweet-
Mark your calendars: 2 day-breast cancer meeting with @harvardmed @DanaFarber faculty led by @DrHBurstein ! can't miss it! https://t.co/6wbnQNmU7y
-
-
Mashup Score: 17
This intensive course, developed by the International Society for Stem Cell Research (ISSCR), offers a comprehensive exploration of key topics in stem cell medicine. Designed for clinicians, medical students, and health care professionals, the curriculum is structured into seven modules providing an overview of the field, from basic stem cell biology and clinical trials to ethical considerations surrounding unproven stem cell interventions and patient communication.Through expert-led lectures, this course equips health care providers with the knowledge needed to guide patients toward informed, evidence-based decisions while protecting them from unsafe and unproven treatments. It promotes responsible practices and aims to ensure that clinicians are well-prepared to navigate the challenges and opportunities presented by stem cell medicine, ultimately prioritizing patient health and safety.
Source: cmecatalog.hms.harvard.eduCategories: General Medicine News, NeurologyTweet-
If you are a #clinician interested in the future of stem cell medicine, please get your certificate of completion of our FREE online course @HMS and @ISSCR @JAMA_current #STEMCELLMEDICINE @ISSCR @harvardmed https://t.co/hYAJNyjD8S https://t.co/p76IgsRoGr
-
-
Mashup Score: 22Breast Cancer: New Horizons, Current Controversies - 2 month(s) ago
Breast Cancer: New Horizons, Current Controversies is a comprehensive educational curriculum that encompasses the full range of breast cancer care. Topics include mechanisms of disease, improvements in diagnostic methods, treatment innovations, and management of breast cancer survivors. The primary goal of the course is to improve the knowledge, competence, and clinical skills of healthcare professionals who specialize in oncology. As such, the curriculum is well suited for medical, surgical, and radiation oncologists; breast and general surgeons; internists; physician assistants; nurse practitioners; oncology nurses; and other clinicians involved in the care of breast cancer patients. The two-day course is taught by clinical experts in medical oncology, surgical oncology, radiation oncology, and pathology. Each year, the course faculty identify emerging practice gaps in breast oncology and address those gaps by translating the latest scientific knowledge into practical clinical app
Source: cmecatalog.hms.harvard.eduCategories: General Medicine NewsTweet-
Mark your calendars: 2 day-breast cancer meeting with @harvardmed @DanaFarber faculty led by @DrHBurstein ! can't miss it! https://t.co/6wbnQNmU7y
-
-
Mashup Score: 22Breast Cancer: New Horizons, Current Controversies - 2 month(s) ago
Breast Cancer: New Horizons, Current Controversies is a comprehensive educational curriculum that encompasses the full range of breast cancer care. Topics include mechanisms of disease, improvements in diagnostic methods, treatment innovations, and management of breast cancer survivors. The primary goal of the course is to improve the knowledge, competence, and clinical skills of healthcare professionals who specialize in oncology. As such, the curriculum is well suited for medical, surgical, and radiation oncologists; breast and general surgeons; internists; physician assistants; nurse practitioners; oncology nurses; and other clinicians involved in the care of breast cancer patients. The two-day course is taught by clinical experts in medical oncology, surgical oncology, radiation oncology, and pathology. Each year, the course faculty identify emerging practice gaps in breast oncology and address those gaps by translating the latest scientific knowledge into practical clinical app
Source: cmecatalog.hms.harvard.eduCategories: General Medicine NewsTweet-
Mark your calendars: 2 day-breast cancer meeting with @harvardmed @DanaFarber faculty led by @DrHBurstein ! can't miss it! https://t.co/6wbnQNmU7y
-
-
Mashup Score: 8
The goals of this CME program are to increase awareness among clinicians about the need for comprehensive cancer survivorship care and specific areas where improved survivorship care can lead to improved patient outcomes. This program will educate participants regarding the evolving evidence surrounding the unique medical risks and psychosocial concerns that cancer survivors face from diagnosis through long-term survivorship. The participants will learn to recognize evidence-based screening, prevention and management strategies for potential long-term, late effects and how to tailor these for patients at varying risks for problems. This course will also introduce, highlight and encourage the participant to utilize the emerging body of guidelines, tools, and resources that are available to optimize the coordination and delivery of survivorship care. We have added several modules to this second version of our course to address specific groups and types of survivors that were not covered
Source: cmecatalog.hms.harvard.eduCategories: General Medicine NewsTweet-
Calling all healthcare professionals! Enhance your knowledge of cancer survivorship with this on-demand CME course co-directed by @CaPsurvivorship. Discover evidence-based strategies to support your patients' long-term health. #CME #CancerSurvivorship https://t.co/1D3Bo346Yb
-
-
Mashup Score: 1
Have you or your patients suffered from shortfalls in administrative support that have adversely affected your care? When you have inquired about the cause, have you been told, as if about an immutable force of nature like the weather, “It’s the supply chain” or “Everyone is having trouble hiring” or “It’s budget cuts” ?Since the time of Hammurabi, clinicians have been held accountable for their decisions and actions that affect patients. Harm from clinical interventions has been much better delineated and significantly reduced in the two decades following the publication of To Err is Human. However, injuries to patients and to clinicians are increasingly arising from a newly described source, administrative harm. Until recently, administrators in healthcare have played a supporting role. However, as the numbers and decision-making power of administrators in healthcare have burgeoned, the vulnerability of patients to the consequences of administratively driven interventions or failure
Source: cmecatalog.hms.harvard.eduCategories: General Medicine News, PulmonologyTweet-
The Second Harvard International Conference on Administrative Harm, Professionalism and Teamwork in Medicine is coming - sign up here, for in person or virtual https://t.co/2FnW1zaFHN
-
-
Mashup Score: 7Topics in Gastrointestinal Oncology - Overview - 5 month(s) ago
This course is designed to give medical oncologists, surgeons, radiation oncologists, gastroenterologists, primary care physicians, nurses, and other interested clinicians updated information regarding the management of gastrointestinal cancers. Specialists from the Dana-Farber Cancer Institute and partner institutions will discuss specifically those topics outlined on the agenda for 2025. Registrants will be encouraged to present their own problem cases for discussion by the clinician panel and are encouraged to bring case materials including scans and other diagnostic information. Engaging learning formats such as: ask the expert, Q&A, case-based discussions and didactic lectures will be incorporated to allow the learners the opportunity to interact with the faculty. The course is designed to change learner competence. Who Should AttendPhysiciansSpecialty PhysicianNurse PractitionersNursePhysician AssistantGastroenterologistsRadiation OncologistsSurgical OncologistsMedical Oncologi
Source: cmecatalog.hms.harvard.eduCategories: General Medicine News, Oncologists1Tweet-
On February 8th, Dana-Farber experts and specialists from partner institutions will discuss gastrointestinal oncology topics during a Continuing Medical Education course for providers only. For additional information and to register, visit https://t.co/FIpM9ibM0R.
-
Mark your calendars: 2 day-breast cancer meeting with @harvardmed @DanaFarber faculty led by @DrHBurstein ! can't miss it! https://t.co/6wbnQNmU7y